Johnson & Johnson is a Humankind 100 company whose ranking is based on its Humankind Value, a proprietary metric that provides an estimate of the overall dollar amount a company creates for investors, consumers, employees, and society at large.
Johnson & Johnson develops medical devices and researches and produces pharmaceuticals. Its business segments include MedTech, which specializes in surgery, orthopedics, vision, and interventional solutions, and a pharmaceutical arm, Janssen Pharmaceuticals, which works to treat diseases.
(All values are in US Dollars, where M=Million, B=Billion, T=Trillion.)
Johnson & Johnson is a net-positive Humankind Value company. Notable sources of positive value are Healthcare R&D ($291.6 B), Medical Devices ($191.5 B), and Pharmaceuticals ($165.3 B). The positive value it creates due to its work in Healthcare R&D, Medical Devices, and Pharmaceuticals includes an estimated 12,000,000 additional years lived by people worldwide. However, there is room for improvement with respect to Greenhouse Gases (-$5.9 B) and Biofuel Production (-$3.4 B). Healthcare R&D, Medical Devices, Pharmaceuticals, and Greenhouse Gases are attached to this company as a result of its direct business activities. Biofuel Production is mostly or entirely a result of Johnson & Johnson’s supply-chain relationships.